Latest news
Sun Pharma share: Citi maintains buy, sees 35% upside on innovation revenue growth and global expansion - Business UpturnBusiness Upturn · Wed, 05 Aug 2026 17:16:05 GMTSun Pharma maintains FY27 growth outlook, says Organon deal remains on track - CNBC TV18CNBC TV18 · Mon, 03 Aug 2026 10:33:46 GMTSun Eyes Expanded Indications For Leqselvi And Unloxcyt, Wider Semaglutide Play - insights.citeline.cominsights.citeline.com · Mon, 03 Aug 2026 09:23:27 GMTSun Pharma Q1 Review: Brokerages Back India Growth, Flag Specialty Slowdown - NDTV ProfitNDTV Profit · Mon, 03 Aug 2026 02:49:39 GMTSun Pharma’s Leqselvi tops 1000 prescribers in US; seasonal shifts hits Levulan - ET PharmaET Pharma · Sat, 01 Aug 2026 02:37:36 GMTSun Pharma banks on specialty drug portfolio, India business to drive growth in FY27 - Moneycontrol.comMoneycontrol.com · Fri, 31 Jul 2026 07:00:00 GMT